Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

COVID-19 In Vitro Diagnostic Medical Device - detail

Rapid COVID-19 Antigen Test(Colloidal Gold)

Manufactured by Anbio (Xiamen) Biotechnology Co., Ltd., China - www.anbio.com 

Device identification number
2239
CE Marking
Yes
HSC common list
×No
HSC mutual recognition
×No
Format
Near POC / POC
Physical Support
Cassette
Target
Antigen
Specimen
Nasal swab, Saliva, Throat swab
Pathogens detected
Adenovirus, Adenovirus 3, Adenovirus 7, Alpha Coronavirus 229E (HCoV-229E), Alpha Coronavirus Nl63 (HCoV-Nl63), Beta Coronavirus HKU1 (HCoV-HKU1), Bordetella Pertussis, Chlamydia Pneumoniae, Coronaviruses (HCoV), Enterovirus A71 (EV-A71), Epstein-Barr Virus (EBV), Human Metapneumovirus (HMPV), Influenza A, Influenza A H1N1, Influenza A H3N2, Influenza A H5N1, Influenza B, Influenza B Victoria, Influenza B Yamagata, MERS-CoV, Mumps Virus (MuV), Mycobacterium Tuberculosis, Mycoplasma Pneumoniae, Parainfluenza Virus Type 1, Parainfluenza Virus Type 2, Parainfluenza Virus Type 3, Respiratory Syncytial V (RSV), Respiratory Syncytial V (RSV) Type A, Respiratory Syncytial V (RSV) Type B, Rhinovirus, Rhinovirus A, Rhinovirus B, SARS-CoV, Varicella Zoster Virus (VZV)
Commercial Status
Commercialised
Last Update
2021-06-11 05:49:34 CET
Comments
Approved by Germany Approved by Paul-Ehrlich-Institut,list on BfArm self test list,the number is 5640-S-058(saliva)and 5640-S-310(Nasal Swab).According to the evaluation report of PacGenomics Clinical Genetics Laboratory in the United States, the sensitivity and specificity of Anbio's Rapid COVID-19 Antigen test kit (Colloidal Gold) are 98.51% and 99.63%.
Assay Type
Immuno-Antigen
Reader Required
No
Method
Immunochromatography
Measurement
Quantitative
Time
15 minutes
Subclass
Sandwich
Detection Principle
Colloidal gold
LOD
150 AU
Calibration
Evaluated
Crossreactivity
Evaluated
Fp
0 %
Fn
1 AU
Precision
Evaluated
Accuracy
99.52 %
Reproducibility
Evaluated
Robustness
Evaluated
Clinical Sensitivity
99.18 %
Clinical Specificity
100 %
Type of antigen
Nucleoprotein

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements